Nebulized Heparin and N-Acetylcysteine do Not Improve Outcomes of Intubated Burn Patients With Grade II or III Inhalation Injuries
The American Surgeon™ · 2025-08 · 91 (8) · 1392-1395
DOI: 10.1177/00031348251337148 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 10.05.2025. Verfasst von William B Risinger und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA. Hauptthemen laut MEDLINE: Acetylcysteine, Heparin, Burns, Inhalation, Smoke Inhalation Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Inhalation injuries heighten the morbidity and mortality associated with burn injury. Nebulized heparin and N-acetylcysteine have been proposed as adjunctive treatments for severe inhalation injury. In this study, a total of 100 inhalation injuries were identified over a 4-year period, with 40 patients suffering grade II-III inhalation injuries confirmed via fiberoptic bronchoscopy. 47.5% of patients received the inhalation protocol of nebulized heparin, N-acetylcysteine, and albuterol. Patient demographics and inhalation injury grade were similar between the groups (2 vs 2, P = .20). The utilization of the inhalation protocol did not shorten the number of ventilator days (5 vs 6, P = .76) or show survival benefit (57.9 vs 52.4%, P = .73). An inhalational protocol did not improve outcomes in burn patients suffering abbreviated injury score (AIS) grade II-III inhalation injuries at our institution. Moving forward, large, multicenter, randomized control trials are needed to determine the true efficacy of nebulized heparin and N-acetylcysteine for AIS grade II-III injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Louisville School of Medicine, Louisville, KY, USA.
ORCID-Profile: William B Risinger, Victoria R Hammond, Keith R Miller
Zitieren
APA
Risinger, W. B., Hammond, V. R., Uma, C. V., Sims, B. L., Keeven, D. D., Dye, C. N., Franklin, G. A., Smith, J. W., Miller, K. R., Benns, M. V., Nash, N. A., Pera, S. J., Marshall, G. R., Coleman, J. C., Harbrecht, B. G., & Bozeman, M. C. (2025). Nebulized Heparin and N-Acetylcysteine do Not Improve Outcomes of Intubated Burn Patients With Grade II or III Inhalation Injuries. The American Surgeon™, 91(8), 1392-1395. https://doi.org/10.1177/00031348251337148
Vancouver
Risinger WB, Hammond VR, Uma CV, Sims BL, Keeven DD, Dye CN, et al. Nebulized Heparin and N-Acetylcysteine do Not Improve Outcomes of Intubated Burn Patients With Grade II or III Inhalation Injuries. The American Surgeon™. 2025;91(8):1392-1395. doi:10.1177/00031348251337148
BibTeX
@article{Risinger2025,
author = {Risinger, William B and Hammond, Victoria R and Uma, Chinweotuto V and Sims, Brittany L and Keeven, David D and Dye, Crystal N and Franklin, Glen A and Smith, Jason W and Miller, Keith R and Benns, Matthew V and Nash, Nicholas A and Pera, Samuel J and Marshall, George R and Coleman, Jamie C and Harbrecht, Brian G and Bozeman, Matthew C},
title = {Nebulized Heparin and N-Acetylcysteine do Not Improve Outcomes of Intubated Burn Patients With Grade II or III Inhalation Injuries},
journal = {The American Surgeon™},
year = {2025},
volume = {91},
number = {8},
pages = {1392--1395},
doi = {10.1177/00031348251337148}
}
EUVIMED